Constellation Brands (NYSE:STZ – Get Free Report) and Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) are both consumer staples companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings.
Volatility & Risk
Constellation Brands has a beta of 0.39, indicating that its share price is 61% less volatile than the S&P 500. Comparatively, Arcadia Biosciences has a beta of 0.63, indicating that its share price is 37% less volatile than the S&P 500.
Profitability
This table compares Constellation Brands and Arcadia Biosciences’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Constellation Brands | 19.57% | 24.75% | 9.54% |
| Arcadia Biosciences | -202.09% | -203.20% | -90.95% |
Analyst Recommendations
This is a breakdown of current ratings for Constellation Brands and Arcadia Biosciences, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Constellation Brands | 4 | 8 | 12 | 0 | 2.33 |
| Arcadia Biosciences | 1 | 0 | 0 | 0 | 1.00 |
Constellation Brands presently has a consensus target price of $154.09, indicating a potential upside of 8.59%. Given Constellation Brands’ stronger consensus rating and higher probable upside, equities analysts plainly believe Constellation Brands is more favorable than Arcadia Biosciences.
Institutional & Insider Ownership
77.3% of Constellation Brands shares are held by institutional investors. Comparatively, 17.7% of Arcadia Biosciences shares are held by institutional investors. 12.2% of Constellation Brands shares are held by company insiders. Comparatively, 4.5% of Arcadia Biosciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Valuation & Earnings
This table compares Constellation Brands and Arcadia Biosciences”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Constellation Brands | $9.76 billion | 2.46 | $1.69 billion | $11.15 | 12.73 |
| Arcadia Biosciences | $4.86 million | 0.09 | -$2.34 million | ($4.89) | -0.04 |
Constellation Brands has higher revenue and earnings than Arcadia Biosciences. Arcadia Biosciences is trading at a lower price-to-earnings ratio than Constellation Brands, indicating that it is currently the more affordable of the two stocks.
Summary
Constellation Brands beats Arcadia Biosciences on 13 of the 14 factors compared between the two stocks.
About Constellation Brands
Constellation Brands is a beverage alcohol company focused on beer, wine and spirits. Its beer portfolio includes Modelo Especial, Corona Extra and Pacifico, which it markets in the United States under its agreement with Grupo Modelo. The company also owns premium wine and spirits brands, including Robert Mondavi Winery and The Prisoner Wine Company. Its products reach consumers primarily in the United States, with operations and distribution extending to other markets. Founded in 1945 as Canandaigua Wine Company in New York, the business grew through brand development and acquisitions before adopting the Constellation Brands name.
About Arcadia Biosciences
Arcadia Biosciences, Inc. is an agricultural biotechnology and food company focused on developing and commercializing plant-based products. The company has historically used plant breeding and biotechnology to develop crop traits, including traits intended to improve crop performance and the nutritional qualities of food. Its consumer-facing GoodWheat brand is built around wheat varieties bred for higher fiber and protein content. Products have included wheat flour, pasta and crackers, which are marketed to consumers seeking more nutritious options made with familiar grain ingredients.
Receive News & Ratings for Constellation Brands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Constellation Brands and related companies with MarketBeat.com's FREE daily email newsletter.
